KIMURA, T., Michaela BOSÁKOVÁ, Y. NONAKA, Eva HRUBA, K. YASUDA, S. FUTAKAWA, T. KUBOTA, Bohumil FAFÍLEK, Tomáš GREGOR, Sara POOVAKULATHU ABRAHAM, Regína GOMOLKOVÁ, Silvie BELASKOVA, Martin PEŠL, F. CSUKASI, I. DURAN, M. FUJIWARA, Michaela KAVKOVA, Tomas ZIKMUND, Josef KAISER, Marcela BUCHTOVÁ, D. KRAKOW, Y. NAKAMURA, K. OZONO and Pavel KREJČÍ. An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice. Science Translational Medicine. Washington: American Association for the Advancement of Science, 2021, vol. 13, No 592, p. "eaba4226", 14 pp. ISSN 1946-6234. Available from: https://dx.doi.org/10.1126/scitranslmed.aba4226.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice
Authors KIMURA, T., Michaela BOSÁKOVÁ (203 Czech Republic, belonging to the institution), Y. NONAKA, Eva HRUBA (203 Czech Republic), K. YASUDA, S. FUTAKAWA, T. KUBOTA, Bohumil FAFÍLEK (203 Czech Republic, belonging to the institution), Tomáš GREGOR (203 Czech Republic, belonging to the institution), Sara POOVAKULATHU ABRAHAM (356 India, belonging to the institution), Regína GOMOLKOVÁ (203 Czech Republic, belonging to the institution), Silvie BELASKOVA (203 Czech Republic), Martin PEŠL (203 Czech Republic, belonging to the institution), F. CSUKASI, I. DURAN, M. FUJIWARA, Michaela KAVKOVA (203 Czech Republic), Tomas ZIKMUND (203 Czech Republic), Josef KAISER (203 Czech Republic), Marcela BUCHTOVÁ (203 Czech Republic, belonging to the institution), D. KRAKOW, Y. NAKAMURA, K. OZONO and Pavel KREJČÍ (203 Czech Republic, guarantor, belonging to the institution).
Edition Science Translational Medicine, Washington, American Association for the Advancement of Science, 2021, 1946-6234.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 19.319
RIV identification code RIV/00216224:14110/21:00119123
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1126/scitranslmed.aba4226
UT WoS 000648584600002
Keywords in English RNA aptamer; defective bone growth; FGFR3-related skeletal dysplasia; mice
Tags 14110115, 14110513, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 28/2/2022 10:06.
Abstract
Achondroplasia is the most prevalent genetic form of dwarfism in humans and is caused by activating mutations in FGFR3 tyrosine kinase. The clinical need for a safe and effective inhibitor of FGFR3 is unmet, leaving achondroplasia currently incurable. Here, we evaluated RBM-007, an RNA aptamer previously developed to neutralize the FGFR3 ligand FGF2, for its activity against FGFR3. In cultured rat chondrocytes or mouse embryonal tibia organ culture, RBM-007 rescued the proliferation arrest, degradation of cartilaginous extracellular matrix, premature senescence, and impaired hypertrophic differentiation induced by FGFR3 signaling. In cartilage xenografts derived from induced pluripotent stem cells from individuals with achondroplasia, RBM-007 rescued impaired chondrocyte differentiation and maturation. When delivered by subcutaneous injection, RBM-007 restored defective skeletal growth in a mouse model of achondroplasia. We thus demonstrate a ligand-trap concept of targeting the cartilage FGFR3 and delineate a potential therapeutic approach for achondroplasia and other FGFR3-related skeletal dysplasias.
Links
GA17-09525S, research and development projectName: Neobvyklé signální dráhy lidských receptorových tyrozinových kináz
Investor: Czech Science Foundation
GA19-20123S, research and development projectName: Regulace časného vývoje savčí končetiny pomocí nestabilních morfogenů z rodiny FGF (Acronym: Regulace časného vývoje savčí končetiny)
Investor: Czech Science Foundation
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1325/2020, interní kód MUName: Biomedicínské vědy
Investor: Masaryk University
PrintDisplayed: 11/5/2024 11:13